⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

UTHR

United Therapeutics Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

587.50USD

+2.7100 (+0.46%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on UTHR.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 587.50
P/E19.2
Dvd Ind Yld0.0%
P/B3.94
P/S8.0
Curr EV/T12M EBITDA15.1
Mkt Cap (USD)25.2B
Curr EV (USD)22.5B
2)

Per Share Data

EPS T12M27.86
DPS—
Bk Val Per Sh149.97
Rev/Sh68.88
Cash/Sh62.07
Curr Shares Out42.9M
FCF/Sh23.86
3)

Cash Flow Analysis

P/CF15.0
Curr P/FCF23.1
CF/NI1.3
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales53.4%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr13.1%
Cap 1Y Gr10.1%
BPS 1Y Gr11.5%
R&D To Sales17.5%
Retention Rate100.0%
Rev 1Y Gr10.6%
FCF 1Y Gr-3.7%
Assets 1Y Gr7.0%
5)

Profitability

EBITDA1.5B
EBIT1.4B
Operating Margin44.4%
Pretax Margin49.9%
Net Margin41.6%
ROA17.3%
ROE19.3%
ROC18.3%
Asset Turnover0.42
6)

Structure

Current Ratio5.73
Quick Ratio4.89
Debt/Assets0.0%
Debt/Com Eq0.0%
Net Debt/EBITDA-1.21
Tot Debt/Capital0.0%
Gross Margin86.1%
EBIT/Int Exp116.8

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.